BioNTech

Latest news

• Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (opens in a new tab)

  Yahoo Finance · Oct 1, 2026

• Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (opens in a new tab)

  24/7 Wall St. · Oct 1, 2026

• Under a June 3 trading plan, BioNTech (BNTX) CEO Ugur Sahin sells 34,000 and 32,000 shares. (opens in a new tab)

  Stock Titan · Sep 30, 2026

• Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? (opens in a new tab)

  Zacks Investment Research · Sep 30, 2026

• BioNTech to close German manufacturing plants after failing to find buyers (opens in a new tab)

  BioSpace · Sep 30, 2026

• Is BioNTech (BNTX) Undervalued As It Closes Vaccine Plants And Restructures? (opens in a new tab)

  Simply Wall Street · Sep 30, 2026

• BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common Stock (opens in a new tab)

  Moomoo · Sep 29, 2026

• Pfizer, BioNTech and Moderna Must Face Bayer Patent Lawsuits Over COVID-19 Vaccines (opens in a new tab)

  Law Commentary · Sep 29, 2026

• BioNTech closes four sites after failed sale process as post-COVID vaccine sales slump (opens in a new tab)

  Manufacturing Chemist · Sep 29, 2026

• BioNTech to close three sites in Germany after failing to secure a sale (opens in a new tab)

  Endpoints News · Sep 29, 2026

• BioNTech to close three German plants after failing to find buyers (opens in a new tab)

  medwatch.com · Sep 29, 2026

• BioNTech to close Germany and Singapore sites after sale fails (opens in a new tab)

  StreetInsider · Sep 29, 2026

• Can Vaccine Approval Change The Bull Case For BioNTech (BNTX)? (opens in a new tab)

  Simply Wall Street · Sep 29, 2026

• Germany news: COVID vaccine maker BioNTech to close 3 sites (opens in a new tab)

  DW.com · Sep 28, 2026

• Biontech Insider Sold Shares Worth $6,012,500, According to a Recent SEC Filing (opens in a new tab)

  marketscreener.com · Sep 28, 2026

• A trading plan covers BioNTech (BNTX) CEO Ugur Sahin's sales of 27,000 and 34,000 shares. (opens in a new tab)

  Stock Titan · Sep 28, 2026

• Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits (PFE:NYSE) (opens in a new tab)

  Seeking Alpha · Sep 28, 2026

• BioNTech to shutter three sites in Germany as no buyers emerge (opens in a new tab)

  Reuters · Sep 28, 2026

• Pfizer, BioNTech and Moderna lose bid to dismiss Bayer patent case (opens in a new tab)

  Investing.com · Sep 28, 2026

• Covid vaccine -BioNTech shuts down in Germany (opens in a new tab)

  realnewsmagazine.net · Sep 28, 2026

• BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts (opens in a new tab)

  marketscreener.com · Sep 28, 2026

• Market Chatter: BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts (opens in a new tab)

  Yahoo Finance · Sep 28, 2026

• Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside? (opens in a new tab)

  The Globe and Mail · Sep 28, 2026

• BioNTech to close 3 sites in Germany after failed buyer search (opens in a new tab)

  Fierce Pharma · Sep 28, 2026

• BioNTech Plans To Close Unsold German Vaccine Plants (opens in a new tab)

  Finimize · Sep 28, 2026

• BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process Ends (opens in a new tab)

  Yahoo Finance · Sep 28, 2026

• BioNTech to shutter sites in Germany, Singapore as no buyers emerge (opens in a new tab)

  TradingView · Sep 28, 2026

• Covid vaccine maker BioNTech to close three sites in Germany (opens in a new tab)

  Yahoo Finance · Sep 28, 2026

• BioNTech to close 3 German plants (opens in a new tab)

  Breakingthenews.net · Sep 28, 2026

• BioNTech SE ADR Advanced Charts | BNTX (opens in a new tab)

  Barron's · Sep 28, 2026